80 related articles for article (PubMed ID: 15357975)
1. 4-Aryl-3-(mercapto)quinolin-2-ones: novel maxi-K channel opening relaxants of corporal smooth muscle.
Hewawasam P; Fan W; Cook DA; Newberry KS; Boissard CG; Gribkoff VK; Starrett J; Lodge NJ
Bioorg Med Chem Lett; 2004 Sep; 14(17):4479-82. PubMed ID: 15357975
[TBL] [Abstract][Full Text] [Related]
2. 4-Aryl-3-(hydroxyalkyl)quinolin-2-ones: novel maxi-K channel opening relaxants of corporal smooth muscle targeted for erectile dysfunction.
Hewawasam P; Fan W; Ding M; Flint K; Cook D; Goggins GD; Myers RA; Gribkoff VK; Boissard CG; Dworetzky SI; Starrett JE; Lodge NJ
J Med Chem; 2003 Jul; 46(14):2819-22. PubMed ID: 12825925
[TBL] [Abstract][Full Text] [Related]
3. Potassium channels and human corporeal smooth muscle cell tone: further evidence of the physiological relevance of the Maxi-K channel subtype to the regulation of human corporeal smooth muscle tone in vitro.
Spektor M; Rodriguez R; Rosenbaum RS; Wang HZ; Melman A; Christ GJ
J Urol; 2002 Jun; 167(6):2628-35. PubMed ID: 11992099
[TBL] [Abstract][Full Text] [Related]
4. 3-Thio-quinolinone maxi-K openers for the treatment of erectile dysfunction.
Boy KM; Guernon JM; Sit SY; Xie K; Hewawasam P; Boissard CG; Dworetzky SI; Natale J; Gribkoff VK; Lodge N; Starrett JE
Bioorg Med Chem Lett; 2004 Oct; 14(20):5089-93. PubMed ID: 15380205
[TBL] [Abstract][Full Text] [Related]
5. Effect of 4-(5-chloro-2-hydroxyphenyl)-3-(2-hydroxyethyl)-6-(trifluoromethyl)-quinolin-2(1H)-one (BMS-223131), a novel opener of large conductance Ca2+-activated K+ (maxi-K) channels on normal and stress-aggravated colonic motility and visceral nociception.
Sivarao DV; Newberry K; Langdon S; Lee AV; Hewawasam P; Plym MJ; Signor L; Myers R; Lodge NJ
J Pharmacol Exp Ther; 2005 May; 313(2):840-7. PubMed ID: 15701710
[TBL] [Abstract][Full Text] [Related]
6. The synthesis and structure-activity relationships of 4-aryl-3-aminoquinolin-2-ones: a new class of calcium-dependent, large conductance, potassium (maxi-K) channel openers targeted for post-stroke neuroprotection.
Hewawasam P; Fan W; Knipe J; Moon SL; Boissard CG; Gribkoff VK; Starrett JE
Bioorg Med Chem Lett; 2002 Jul; 12(13):1779-83. PubMed ID: 12067560
[TBL] [Abstract][Full Text] [Related]
7. Novel 1,4-benzothiazine derivatives as large conductance Ca2+-activated potassium channel openers.
Calderone V; Spogli R; Martelli A; Manfroni G; Testai L; Sabatini S; Tabarrini O; Cecchetti V
J Med Chem; 2008 Aug; 51(16):5085-92. PubMed ID: 18680269
[TBL] [Abstract][Full Text] [Related]
8. Analogs of a potent maxi-K potassium channel opener with an improved inhibitory profile toward cytochrome P450 isozymes.
Vrudhula VM; Dasgupta B; Boissard CG; Gribkoff VK; Santone KS; Dalterio RA; Lodge NJ; Starrett JE
Bioorg Med Chem Lett; 2005 Oct; 15(19):4286-90. PubMed ID: 16061379
[TBL] [Abstract][Full Text] [Related]
9. The synthesis and structure-activity relationships of 1,3-diaryl 1,2,4-(4H)-triazol-5-ones: a new class of calcium-dependent, large conductance, potassium (maxi-K) channel opener targeted for urge urinary incontinence.
Hewawasam P; Erway M; Thalody G; Weiner H; Boissard CG; Gribkoff VK; Meanwell NA; Lodge N; Starrett JE
Bioorg Med Chem Lett; 2002 Apr; 12(7):1117-20. PubMed ID: 11909730
[TBL] [Abstract][Full Text] [Related]
10. 3-[(5-Chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl ]-1,3,4-oxadiazol-2(3H)-one, BMS-191011: opener of large-conductance Ca(2+)-activated potassium (maxi-K) channels, identification, solubility, and SAR.
Romine JL; Martin SW; Meanwell NA; Gribkoff VK; Boissard CG; Dworetzky SI; Natale J; Moon S; Ortiz A; Yeleswaram S; Pajor L; Gao Q; Starrett JE
J Med Chem; 2007 Feb; 50(3):528-42. PubMed ID: 17266205
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat.
Melman A; Biggs G; Davies K; Zhao W; Tar MT; Christ GJ
Gene Ther; 2008 Mar; 15(5):364-70. PubMed ID: 18200069
[TBL] [Abstract][Full Text] [Related]
12. Atropisomeric 3-(beta-hydroxyethyl)-4-arylquinolin-2-ones as Maxi-K potassium channel openers.
Vrudhula VM; Dasgupta B; Qian-Cutrone J; Kozlowski ES; Boissard CG; Dworetzky SI; Wu D; Gao Q; Kimura R; Gribkoff VK; Starrett JE
J Med Chem; 2007 Mar; 50(5):1050-7. PubMed ID: 17274609
[TBL] [Abstract][Full Text] [Related]
13. 4,5-diphenyltriazol-3-ones: openers of large-conductance Ca(2+)-activated potassium (maxi-K) channels.
Romine JL; Martin SW; Gribkoff VK; Boissard CG; Dworetzky SI; Natale J; Li Y; Gao Q; Meanwell NA; Starrett JE
J Med Chem; 2002 Jul; 45(14):2942-52. PubMed ID: 12086481
[TBL] [Abstract][Full Text] [Related]
14. Time-dependent alteration in cromakalim-induced relaxation of corpus cavernosum from streptozocin-induced diabetic rats.
Ghasemi M; Sadeghipour H; Asadi S; Dehpour AR
Life Sci; 2007 Sep; 81(12):960-9. PubMed ID: 17825847
[TBL] [Abstract][Full Text] [Related]
15. Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function.
Christ GJ; Rehman J; Day N; Salkoff L; Valcic M; Melman A; Geliebter J
Am J Physiol; 1998 Aug; 275(2):H600-8. PubMed ID: 9683449
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of 3-aryloxindoles: a new class of calcium-dependent, large conductance potassium (maxi-K) channel openers with neuroprotective properties.
Hewawasam P; Erway M; Moon SL; Knipe J; Weiner H; Boissard CG; Post-Munson DJ; Gao Q; Huang S; Gribkoff VK; Meanwell NA
J Med Chem; 2002 Mar; 45(7):1487-99. PubMed ID: 11906290
[TBL] [Abstract][Full Text] [Related]
17. The amiodarone derivative 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015) opens large-conductance Ca2+-activated K+ channels and relaxes vascular smooth muscle.
Gessner G; Heller R; Hoshi T; Heinemann SH
Eur J Pharmacol; 2007 Jan; 555(2-3):185-93. PubMed ID: 17134694
[TBL] [Abstract][Full Text] [Related]
18. K+ channels and gap junctions in the modulation of corporal smooth muscle tone.
Christ GJ
Drug News Perspect; 2000 Feb; 13(1):28-36. PubMed ID: 12937650
[TBL] [Abstract][Full Text] [Related]
19. Plasmid-based gene transfer for treatment of erectile dysfunction and overactive bladder: results of a phase I trial.
Melman A; Bar-Chama N; McCullough A; Davies K; Christ G
Isr Med Assoc J; 2007 Mar; 9(3):143-6. PubMed ID: 17402321
[TBL] [Abstract][Full Text] [Related]
20. [Involvement of voltge dependent potassium channels in rabbit corpus cavernosum responses to oxidative stress].
Buryĭ VO; Hurkovs'ka AV; Sukhanova KIu; Sahach VF
Fiziol Zh (1994); 2007; 53(6):34-9. PubMed ID: 18309629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
